29/01
AmoyDx Announces Its PLC Panel Adopted as Companion Diagnostic for Brigatinib in Japan
Xiamen, China, January 29, 2022 - Amoy Diagnostics Co., Ltd. (AmoyDx, SZSE: 300685), an innovative commercial-stage in vitro diagnostic (IVD) company today announced that the AmoyDx Pan Lung Cancer PCR Panel (the “PLC Panel”) has been adopted by Takeda Ph
14/01
AmoyDx and PREMIA Announce the Commercial Launch of the AmoyDx® Pan Lung Cancer PCR Panel in Japan
Xiamen and Hong Kong, January 14, 2022 -- Amoy Diagnostics Co., Ltd., (“AmoyDx”) and PREMIA Holdings (HK) Limited (“PREMIA”) today announced the commercial launch of the AmoyDx® Pan Lung Cancer PCR Panel (the “PLC Panel”) in Japan as a reimbursed companio
10/12
AmoyDx Distributors Annual Meeting 2021
Xiamen, China, December 10, 2021 - Amoy Diagnostics Co. Ltd. (AmoyDx) Distributors Annual Meeting 2021 was held recently. Over 100 delegates from about 40 countries or regions gathered together virtually.
09/12
Amoy Diagnostics and Janssen China Sign MoU on Strategic Collaboration
Xiamen China, December 9, 2021 – Amoy Diagnostics Co., Ltd. (AmoyDx, SZSE: 300685) recently signed a Memorandum of Understanding (MoU) on strategic collaboration with The Janssen Pharmaceutical Companies of Johnson & Johnson. In this cooperation, both par
14/10
Visit AmoyDx at ESGO 2021 in Prague, Czech Republic
AmoyDx will be exhibiting at ESGO in Prague, Czech Republic from 23 Oct. - 25 Oct. 2021. Please block your calendar and be sure to stop by our booth 6#, 2nd floor, Prague Congress Centre.
19/08
AmoyDx Collaborates with Amgen to Develop Companion Diagnostics for Japan Market
Xiamen, China, Aug 19, 2021 - Amoy Diagnostics Co., Ltd. (AmoyDx, SZSE: 300685), an innovative commercial-stage in vitro diagnostic (IVD) company, and Amgen Inc. (NASDAQ: AMGN), announced today that the companies have entered into a strategic collaboratio
Inquiry
* Required information
Manage your account info
Change your password